Fig. 2From: Correlation of distribution characteristics and dynamic changes of gut microbiota with the efficacy of immunotherapy in EGFR-mutated non-small cell lung cancerSubgroup analyses of baseline characteristics and their impact on patient survival. A Forest plot of impact on progression-free survival (PFS). B Forest plot of impact on overall survival (OS). ECOG PS Eastern Cooperative Oncology Group performance status, SCC squamous cell carcinoma, ICIs immune checkpoint inhibitors, Chemo chemotherapy, Ais Anti-angiogenesis, NA non applicable, Inf infinite, ATB antibiotic.Back to article page